Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

Core Viewpoint - The company *ST Zhisheng (002253.SZ)* has been awarded a contract for the "Smart City Governance (Phase IV) Project," which is expected to significantly impact its future revenue [1] Group 1: Contract Details - The company received a "Notice of Winning Bid" from Sichuan Sanying Tendering Agency Co., Ltd. [1] - The total bid amount is 103,869,622.24 yuan, which accounts for 62.82% of the company's audited revenue for the fiscal year 2024 [1] - If the formal contract is signed and the project is successfully implemented, it will have a positive effect on the company's operating performance during the contract execution period [1]

人民财讯12月12日电，*ST智胜（002253）12月12日公告，公司近日收到中标通知书，被确认为"智慧 城市治理(四期)项目"中标单位，中标金额为1.04亿元，占公司2024年度经审计营业收入的62.82%。 ...

每经AI快讯，*ST智胜（SZ 002253，收盘价：9.53元）12月12日晚间发布公告称，近日，四川川大智胜 软件股份有限公司（以下简称"公司"）收到四川三盈招标代理有限公司发出的《中标通知书》。公司被 确认为"智慧城市治理（四期）项目"中标单位。公司中标智慧城市治理（四期）项目。中标金额约1.04 亿元。 2025年1至6月份，*ST智胜的营业收入构成为：软件行业占比99.25%，其他占比0.75%。 截至发稿，*ST智胜市值为22亿元。 每经头条（nbdtoutiao）——专访管涛：美国政府经济贸易政策正逐渐动摇美元本位国际货币体系，利 多因素下人民币汇率有可能破7 （记者 曾健辉） ...

证券代码：002253 证券简称：*ST 智胜 公告编号：2025-060 四川川大智胜软件股份有限公司 关于收到中标通知书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 近日，四川川大智胜软件股份有限公司（以下简称"公司"）收到四川 三盈招标代理有限公司发出的《中标通知书》。公司被确认为"智慧城市治 理（四期）项目"中标单位。现将有关中标信息公告如下： 5、公司与招标人、招标代理机构不存在任何关联关系, 最近一年又一期 与招标人未发生类似交易。 二、 对公司的影响 本次中标金额为103,869,622.24元，占公司2024年度经审计营业收入的 62.82 %。若本项目签订正式合同并顺利实施，将对公司未来合同执行期内的 经营业绩产生积极影响。本次中标不影响公司业务的独立性。 三、 风险提示 截至本公告日，公司尚未签署正式合同，敬请投资者注意投资风险。公 司将密切关注项目的进展情况并及时履行信息披露义务。 一、 中标项目概述 1、项目名称：智慧城市治理（四期）项目 2、招标编号：SYXM2025293 3、招标代理机构：四川三盈招标代理有限公司 4、中 ...

Group 1 - The core point of the announcement is the decision to change the auditing firm for the company, from Sichuan Huaxin (Group) Accounting Firm to Beijing Guofu Jiaying Accounting Firm for the 2025 fiscal year [4][10][18] - The board meeting was held on December 3, 2025, with all seven directors present, and the decision to change the auditing firm was unanimously approved [2][3][22] - The new auditing fees are set at 610,000 yuan for the financial report audit and 120,000 yuan for the internal control audit [4][17] Group 2 - The new auditing firm, Beijing Guofu Jiaying Accounting Firm, was established on August 18, 2020, and has a total of 34 partners and 162 registered accountants [10][12] - The firm has a history of providing auditing services to seven listed companies, with a total revenue of 76.17 million yuan in 2024, including 43.69 million yuan from auditing services [12] - The firm has no record of civil litigation related to its professional conduct in the past three years and has established a professional risk fund of 6.34 million yuan [13][14] Group 3 - The company plans to hold its fourth extraordinary general meeting of shareholders on December 22, 2025, to discuss the proposed change of the auditing firm [6][27] - The meeting will be conducted both in-person and via online voting, with specific time slots for voting outlined [28][29] - The deadline for shareholder registration is December 16, 2025, and shareholders can appoint proxies to attend the meeting [30][35]

证券代码：002253 证券简称：川大智胜 公告编号：2025-058 机构名称：北京国府嘉盈会计师事务所（特殊普通合伙） 成立日期：2020年8月18日 四川川大智胜软件股份有限公司 关于拟变更会计师事务所的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 1、四川川大智胜软件股份有限公司（以下简称"公司"）原聘任的会 计师事务所为四川华信（集团）会计师事务所（特殊普通合伙），现拟聘 任的会计师事务所为北京国府嘉盈会计师事务所（特殊普通合伙）（以下 简称"国府嘉盈会计师事务所"）。 2、拟变更会计师事务所的原因：综合考虑公司业务发展及审计工作需 求，经公司审慎研究与评估，拟聘任国府嘉盈会计师事务所为2025年度财 务报告审计机构和内部控制审计机构。 3、本次拟变更会计师事务所事项符合财政部、国务院国资委、证监会 印发的《国有企业、上市公司选聘会计师事务所管理办法》（财会〔2023〕 4号）的规定。 2025年12月3日，四川川大智胜软件股份有限公司第九届董事会第四次 临时会议审议通过《关于变更会计师事务所的议案》，该议案尚需提交公 司股东会审 ...

证券代码：002253 证券简称：*ST 智胜 公告编号：2025-059 四川川大智胜软件股份有限公司 关于召开2025年第四次临时股东会的通知 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 四川川大智胜软件股份有限公司（以下简称"公司"）第九届董事 会第四次临时会议决定于2025年12月22日（星期一）下午2:00召开公 司2025年第四次临时股东会，现将本次会议的有关事项通知如下： 一、召开会议的基本情况 （一）股东会届次 2025年第四次临时股东会 （二）会议召集人 公司董事会 （三）会议召开的合法、合规性 本次股东会的召集、召开符合《中华人民共和国公司法》《深 圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管 指引第1号—主板上市公司规范运作》等法律、行政法规、部门规章、 规范性文件及《公司章程》的有关规定。 （四）会议召开时间 1. 现场会议时间 2025年12月22日（星期一）下午2:00 2. 网络投票时间 （1）通过深圳证券交易所交易系统进行网络投票的时间为：2025 年12月22日上午9:15-9:25、9:30-11:30，下午13 ...

证券代码：002253 证券简称：*ST 智胜 公告编号：2025-057 四川川大智胜软件股份有限公司 第九届董事会第四次临时会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 一、董事会会议召开情况 四川川大智胜软件股份有限公司（以下简称"公司"）第九届董事会第四 次临时会议在保障董事充分表达意见的前提下，于2025年12月3日以通讯表决 方式召开。本次会议通知由董事会秘书于2025年11月27日以微信等方式向各 位董事及会议参加人发出。 本次会议应出席董事7名，实际出席董事7名。部分高级管理人员列席会 议。 本次会议由董事长游志胜先生主持，其召集、召开程序符合有关法律、 行政法规、部门规章、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于变更会计师事务所的议案》 表决结果: 7票赞成、0票反对、0票弃权。 表决结果: 7票赞成、0票反对、0票弃权。 - 1 - 公司决定于2025年12月22日（星期一）下午2:00召开2025年第四次临时 股东会，《公司关于召开2025年第四次临时股东会的通知》登载于2025年12 ...

*ST智胜公告，公司支付现金购买的成都兴仁科技有限公司70%股权已完成工商变更登记，成都兴仁科 技有限公司成为川大智胜的控股子公司，纳入合并报表范围。 ...